Results Of Phase 1 Clinical Trial Lead Way To Use Of New Class Of Drugs To Treat Aggressive Blood Cancer

Patients whose aggressive lymphomas have relapsed or failed to respond to the current front-line chemotherapy regimen now have an effective second line of attack against their disease... via Health News from Medical News Today Read More Here..